BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch of new testing for aerobic vaginitis (AV).
BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch of new testing for aerobic vaginitis (AV).
Interested in COVID-19 antibody testing? Find out about pop-up blood draw events near you |